PGEN · Company research
Precigen, Inc. Common Stock (PGEN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| (PGEN) Volatility Zones as Tactical Triggers - Stock Traders Daily | (PGEN) Volatility Zones as Tactical Triggers Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 18, 2026 | neutral | 0 | 0.6 |
| PGEN Apr 2027 11.000 call (PGEN270416C00011000) Stock Price, News, Quote & History - Yahoo! Finance Canada | PGEN Apr 2027 11.000 call (PGEN270416C00011000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 18, 2026 | neutral | 0 | 0.6 |
| Precigen Inc Actuals & Estimates (NASDAQ:PGEN) - TradingView | Precigen Inc Actuals & Estimates (NASDAQ:PGEN) TradingView | View source ↗ | TradingView | Oct 16, 2026 | neutral | 0 | 0.6 |
| PGEN Nov 2026 10.000 call (PGEN261120C00010000) Stock Historical Prices & Data - Yahoo Finance - Yahoo! Finance Canada | PGEN Nov 2026 10.000 call (PGEN261120C00010000) Stock Historical Prices & Data - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| PGEN Nov 2026 10.000 call (PGEN261120C00010000) Interactive Stock Chart - Yahoo! Finance Canada | PGEN Nov 2026 10.000 call (PGEN261120C00010000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| $PGEN stock is down 11% today. Here's what we see in our data. - Quiver Quantitative | $PGEN stock is down 11% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 5, 2026 | neutral | 0 | 0.6 |
| Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus | Zacks Research showcased strong performance across its various investment portfolios and rating systems during the week ended October 2, 2026. Multiple stocks received upgrades and delivered significant gains, including CRCT and PGEN surging 32% and 30.8% respectively following recommendation upgrades. The Zacks Rank #1 portfolio outperformed the S&P 500 by 2.3 percentage points year-to-date, while the Focus List portfolio returned 19.86% versus 13.14% for the S&P 500 through August 31, 2026. | View source ↗ | Zacks Investment Research | Oct 5, 2026 | bullish | 1 | 1 |
| PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know - Yahoo Finance | PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | Oct 5, 2026 | neutral | 0 | 0.6 |
| Why Did Precigen (PGEN) Stock Climb After Its Latest Update? - Simply Wall Street | Why Did Precigen (PGEN) Stock Climb After Its Latest Update? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 4, 2026 | neutral | 0 | 0.6 |
| 4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike | With Wall Street experiencing volatility due to Middle East tensions and inflation concerns, the Federal Reserve has raised interest rates for the first time in three years and hints at further hikes. The article recommends four low-beta defensive healthcare stocks as potential investments during this uncertain period: Abbott Laboratories, Corcept Therapeutics, Precigen, and Bausch Health Companies. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 1 | 1 |
| 4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike | With Wall Street experiencing volatility due to Middle East tensions and inflation concerns, the Federal Reserve has raised interest rates for the first time in three years and hints at further hikes. The article recommends four low-beta defensive healthcare stocks as potential investments during this uncertain period: Abbott Laboratories, Corcept Therapeutics, Precigen, and Bausch Health Companies. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 1 | 1 |
| Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? | Economic data shows mixed signals with softer-than-expected PCE inflation and stronger-than-expected Q2 GDP growth. Market attention is turning to Friday's employment report. Precigen shares surged 6.3% on growing investor confidence in sales of its FDA-approved drug Papzimeos for recurrent respiratory papillomatosis, with expected quarterly earnings up 181.8% year-over-year. | View source ↗ | Zacks Investment Research | Oct 1, 2026 | bullish | 0.5 | 1 |
| Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance | Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 1, 2026 | neutral | 0 | 0.6 |
| PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? - Yahoo Finance | PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 30, 2026 | neutral | 0 | 0.6 |
| Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? - Yahoo Finance | Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 26, 2026 | neutral | 0 | 0.6 |
| MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - Stocktwits | MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? Stocktwits | View source ↗ | Stocktwits | Sep 25, 2026 | neutral | 0 | 0.6 |
| Reasons Why Investors Should Consider Betting on PGEN Stock - Zacks Investment Research | Reasons Why Investors Should Consider Betting on PGEN Stock Zacks Investment Research | View source ↗ | Zacks Investment Research | Aug 20, 2026 | neutral | 0 | 0.6 |
| Can Precigen (PGEN) Justify Its Valuation On Earnings And PAPZIMEOS Launch? - Yahoo Finance | Can Precigen (PGEN) Justify Its Valuation On Earnings And PAPZIMEOS Launch? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 12, 2026 | neutral | 0 | 0.6 |
| Precigen (PGEN) Stock Valuation Check As High P/B Multiple Meets Large DCF Upside Estimate - Yahoo Finance | Precigen (PGEN) Stock Valuation Check As High P/B Multiple Meets Large DCF Upside Estimate Yahoo Finance | View source ↗ | Yahoo Finance | Jun 14, 2026 | neutral | 0 | 0.6 |
| $PGEN stock is up 15% today. Here's what we see in our data. - Quiver Quantitative | $PGEN stock is up 15% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 11, 2026 | neutral | 0 | 0.6 |
| Is Precigen, Inc. (PGEN) A Good Stock To Buy Now? - Yahoo Finance | Is Precigen, Inc. (PGEN) A Good Stock To Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | May 3, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.